Minutolo R, De Nicola L, Mallamaci F, Zoccali C
Clin Kidney J. 2023; 16(1):41-51.
PMID: 36726437
PMC: 9871852.
DOI: 10.1093/ckj/sfac198.
Solis-Jimenez F, Perez-Navarro L, Cabrera-Barron R, Chida-Romero J, Martin-Alemany G, Dehesa-Lopez E
BMC Nephrol. 2022; 23(1):316.
PMID: 36127661
PMC: 9490943.
DOI: 10.1186/s12882-022-02930-4.
Vakil D, Zinonos S, Kostis J, Dobrzynski J, Cosgrove N, Moreyra A
J Clin Hypertens (Greenwich). 2021; 23(7):1335-1343.
PMID: 34076333
PMC: 8678684.
DOI: 10.1111/jch.14296.
Choi S, Ho C
Redox Rep. 2017; 23(1):1-24.
PMID: 28514939
PMC: 6748682.
DOI: 10.1080/13510002.2017.1324381.
Judd E, Calhoun D, Warnock D
Semin Nephrol. 2014; 34(5):532-9.
PMID: 25416662
PMC: 4450367.
DOI: 10.1016/j.semnephrol.2014.08.007.
Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
Musini V, Nazer M, Bassett K, Wright J
Cochrane Database Syst Rev. 2014; (5):CD003824.
PMID: 24869750
PMC: 10612990.
DOI: 10.1002/14651858.CD003824.pub2.
Chlorthalidone: mechanisms of action and effect on cardiovascular events.
Roush G, Buddharaju V, Ernst M, Holford T
Curr Hypertens Rep. 2013; 15(5):514-21.
PMID: 23839110
DOI: 10.1007/s11906-013-0372-1.
Azilsartan/chlorthalidone combination therapy for blood pressure control.
Cheng J
Integr Blood Press Control. 2013; 6:39-48.
PMID: 23807859
PMC: 3685454.
DOI: 10.2147/IBPC.S34792.
Sustained blood pressure-lowering effect of aliskiren compared with telmisartan after a single missed dose.
Dusing R, Brunel P, Baek I, Baschiera F
J Clin Hypertens (Greenwich). 2013; 15(1):41-7.
PMID: 23282123
PMC: 8108266.
DOI: 10.1111/jch.12018.
Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study.
Sica D, Bakris G, White W, Weber M, Cushman W, Huang P
J Clin Hypertens (Greenwich). 2012; 14(5):284-92.
PMID: 22533654
PMC: 8108928.
DOI: 10.1111/j.1751-7176.2012.00616.x.
Pharmacokinetics of mefruside and two active metabolites in man.
Fleuren H, van Rossum J
Eur J Clin Pharmacol. 1980; 17(1):59-69.
PMID: 7371701
DOI: 10.1007/BF00561678.
Clinical pharmacokinetics of diuretics.
BEERMANN B
Clin Pharmacokinet. 1980; 5(3):221-45.
PMID: 6993083
DOI: 10.2165/00003088-198005030-00003.
Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
Godbillon J, Gerardin A, John V, Theobald W
Eur J Clin Pharmacol. 1983; 24(5):655-60.
PMID: 6873146
DOI: 10.1007/BF00542217.
Pharmacokinetics of chlorthalidone. Dependence of biological half life on blood carbonic anhydrase levels.
MULLEY B, Parr G, RYE R
Eur J Clin Pharmacol. 1980; 17(3):203-7.
PMID: 6767611
DOI: 10.1007/BF00561901.
Pharmacokinetics of chlorthalidone in the elderly after single and multiple doses.
Colussi D, SCHOELLER J, Richard A, Sioufi A
Br J Clin Pharmacol. 1983; 16(6):755-6.
PMID: 6661366
PMC: 1428332.
DOI: 10.1111/j.1365-2125.1983.tb02259.x.
Diuretics. Clinical pharmacology and therapeutic use (Part I).
Lant A
Drugs. 1985; 29(1):57-87.
PMID: 3882391
DOI: 10.2165/00003495-198529010-00003.
Pharmacokinetics of hydroflumethiazide during repeated oral administration to healthy subjects.
Brors O, Jacobsen S
Eur J Clin Pharmacol. 1979; 15(4):281-6.
PMID: 477713
DOI: 10.1007/BF00618518.
Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
Fleuren H, Thien T, van Rossum J
Eur J Clin Pharmacol. 1979; 15(1):35-50.
PMID: 421727
DOI: 10.1007/BF00563556.
